journal article·2026-04-01Open access

Manufacturing Silk Fibroin Hollow Nanoyarns as Fundamental Units for Advanced Medical Textiles

Athanasios Papakonstantinou, Maria Gabriella Fois, Sergio Acosta, Stephan Rütten, Alexander Kopp, Stefan Jockenhoevel, Alicia Fernández-Colino

ACS Applied Materials & Interfaces· Volume 18· Issue 12

Abstract

Nature-inspired designs aim to replicate the hierarchical structure observed in native tissues. Fibers serve as fundamental modular units, enabling the fabrication of complex architectures for the engineering of medical textiles and tissue equivalents. However, synthetic yarns lack inherent biological cues to support tissue integration, leading to a growing interest in yarns derived from natural materials. Here, we describe for the first time the fabrication of hollow nanoyarns from pure silk fibroin (SF) using an advanced funnel electrospinning process. This yielded long SF nanoyarns, spanning several meters, with adequate tensile strength (1.47 MPa) and stretching performance (166.4%). Moreover, the yarns were compatible with autoclaving, permitting effective sterilization and long-term storage, making them suitable for biomedical applications. Indirect cytocompatibility assessment of the scaffolds in accordance with ISO 10993-5 guidelines revealed high metabolic activity for human umbilical vein endothelial cells and human smooth muscle cells, confirming that the scaffolds were nontoxic. Analysis of TNF-α secretion by macrophages showed that the SF scaffolds exhibited low immunogenicity. Furthermore, the structural resilience and flexibility of the yarns supported bottom-up assembly into textile constructs by weaving. This study not only shows for the first time the feasibility of producing SF nanoyarns but also highlights their compelling potential in the field of sustainable and medical textiles.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Silk-based biomaterials and applications · Dyeing and Modifying Textile Fibers · Surface Modification and Superhydrophobicity

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biohybrid & Medical Textiles (BioTex), AME─Institute of Applied Medical Engineering, Helmholtz Institute

RWTH Aachen University

Electron Microscopy Facility

Uniklinik RWTH Aachen University

Fibrothelium GmbH

Funding

Deutsche Forschungsgemeinschaft · Bundesministerium f?r Forschung, Technologie und Raumfahrt

References (77)

Show source-provided references
1. 10.1021/acsnano.8b0108410.1021/acsnano.8b01084 ↗
2. 10.1038/s41563-022-01384-110.1038/s41563-022-01384-1 ↗
3. 10.1016/S1369-7021(06)71743-610.1016/S1369-7021(06)71743-6 ↗
4. 10.1073/pnas.181380111610.1073/pnas.1813801116 ↗
5. 10.1038/nbt105510.1038/nbt1055 ↗
6. 10.1124/pr.109.00128910.1124/pr.109.001289 ↗
7. 10.1016/j.actbio.2008.09.01310.1016/j.actbio.2008.09.013 ↗
8. 10.1038/s41578-018-0023-x10.1038/s41578-018-0023-x ↗
9. 10.1038/nmat408910.1038/nmat4089 ↗
10. 10.1038/nnano.2010.24610.1038/nnano.2010.246 ↗
11. 10.1016/j.biotechadv.2012.11.00710.1016/j.biotechadv.2012.11.007 ↗
12. 10.1179/174328008X35354710.1179/174328008X353547 ↗
13. 10.1016/j.polymer.2008.09.01410.1016/j.polymer.2008.09.014 ↗
14. 10.1002/pen.2624010.1002/pen.26240 ↗
15. 10.1002/adhm.20150051710.1002/adhm.201500517 ↗
16. 10.1002/admt.20210172010.1002/admt.202101720 ↗
17. 10.1002/adma.20080085410.1002/adma.200800854 ↗
18. 10.1007/s12221-014-0954-910.1007/s12221-014-0954-9 ↗
19. 10.1039/D1CC02991F10.1039/D1CC02991F ↗
20. 10.1002/admt.20200068310.1002/admt.202000683 ↗
21. 10.1016/j.actbio.2011.06.01210.1016/j.actbio.2011.06.012 ↗
22. 10.1016/j.mtadv.2025.10065510.1016/j.mtadv.2025.100655 ↗
23. 10.1002/mame.20090040610.1002/mame.200900406 ↗
24. 10.1080/00405000.2011.55225410.1080/00405000.2011.552254 ↗
25. 10.1002/app.4481310.1002/app.44813 ↗
26. 10.1007/s10856-015-5656-310.1007/s10856-015-5656-3 ↗
27. 10.1016/j.apmt.2022.10147310.1016/j.apmt.2022.101473 ↗
28. 10.1126/scitranslmed.300489010.1126/scitranslmed.3004890 ↗
29. 10.1007/s10439-015-1297-410.1007/s10439-015-1297-4 ↗
30. 10.1021/acs.biomac.0c0004510.1021/acs.biomac.0c00045 ↗
31. 10.1016/j.biomaterials.2007.06.02210.1016/j.biomaterials.2007.06.022 ↗
32. 10.1016/j.progpolymsci.2011.07.00310.1016/j.progpolymsci.2011.07.003 ↗
33. 10.1016/j.progpolymsci.2015.02.00410.1016/j.progpolymsci.2015.02.004 ↗
34. 10.1016/j.progpolymsci.2010.10.00110.1016/j.progpolymsci.2010.10.001 ↗
35. 10.1002/adhm.20180046510.1002/adhm.201800465 ↗
36. 10.1016/j.progpolymsci.2007.05.01310.1016/j.progpolymsci.2007.05.013 ↗
37. 10.1126/science.118893610.1126/science.1188936 ↗
38. 10.1038/nprot.2011.37910.1038/nprot.2011.379 ↗
39. 10.1016/S0142-9612(02)00353-810.1016/S0142-9612(02)00353-8 ↗
40. 10.1016/j.bioactmat.2020.01.01010.1016/j.bioactmat.2020.01.010 ↗
41. 10.1038/nmat274510.1038/nmat2745 ↗
42. 10.1021/ab500149p10.1021/ab500149p ↗
43. 10.1016/j.bpj.2009.07.02810.1016/j.bpj.2009.07.028 ↗
44. 10.1038/s41596-021-00622-110.1038/s41596-021-00622-1 ↗
45. 10.1016/j.biomaterials.2010.02.02410.1016/j.biomaterials.2010.02.024 ↗
46. 10.1039/D0BM00816H10.1039/D0BM00816H ↗
47. 10.1016/j.mtbio.2022.10024310.1016/j.mtbio.2022.100243 ↗
48. 10.3109/10731199.2011.63792710.3109/10731199.2011.637927 ↗
49. 10.1016/j.msec.2021.11187210.1016/j.msec.2021.111872 ↗
50. 10.1039/D2TB01890J10.1039/D2TB01890J ↗
51. 10.1088/1748-6041/4/5/05501010.1088/1748-6041/4/5/055010 ↗
52. 10.1016/j.actbio.2019.04.02910.1016/j.actbio.2019.04.029 ↗
53. 10.1038/nmeth.201910.1038/nmeth.2019 ↗
54. 10.1089/ten.tec.2014.021410.1089/ten.tec.2014.0214 ↗
55. 10.1002/admt.20240094610.1002/admt.202400946 ↗
56. ISO 10993–5:2009. Biological Evaluation of Medical Devices Part 5: Tests for in Vitro Cytotoxicity ; International Organization for Standardization, 2009.
57. ISO 10993–12:2021. Biological Evaluation of Medical Devices Part 12: Sample Preparation and Reference Materials ; International Organization for Standardization, 2021.
58. 10.1021/ma061010910.1021/ma0610109 ↗
59. 10.7717/peerj-matsci.810.7717/peerj-matsci.8 ↗
60. 10.1016/S0142-9612(03)00158-310.1016/S0142-9612(03)00158-3 ↗
61. 10.1016/j.actbio.2017.09.02710.1016/j.actbio.2017.09.027 ↗
62. 10.1007/s12221-013-1857-x10.1007/s12221-013-1857-x ↗
63. 10.1002/app.4013710.1002/app.40137 ↗
64. 10.3389/fbioe.2020.52394910.3389/fbioe.2020.523949 ↗
65. European Medicines Agency Guideline on the Sterilization of the Medicinal Product, Active Substance, Excipient and Primary Container , European Medicines Agency; 2019.
66. 10.1002/mabi.20150001310.1002/mabi.201500013 ↗
67. 10.1007/s10853-008-2961-y10.1007/s10853-008-2961-y ↗
68. 10.1021/bm200062a10.1021/bm200062a ↗
69. 10.1002/jbm.a.3770310.1002/jbm.a.37703 ↗
70. 10.1002/mabi.20130032110.1002/mabi.201300321 ↗
71. 10.1016/j.biomaterials.2008.01.02210.1016/j.biomaterials.2008.01.022 ↗
72. 10.1021/acs.biomac.2c0112410.1021/acs.biomac.2c01124 ↗
73. 10.1016/j.tibtech.2016.07.00110.1016/j.tibtech.2016.07.001 ↗
74. 10.1016/j.actbio.2021.04.04710.1016/j.actbio.2021.04.047 ↗
75. Venkatraman P. D. · 2022 · 47110.1016/B978-0-323-85534-1.00004-0 ↗
76. 10.1016/j.actbio.2020.01.03710.1016/j.actbio.2020.01.037 ↗
77. 10.1002/adfm.20231320410.1002/adfm.202313204 ↗